Erythrocyte-αPD-1 conjugates overcome resistance to checkpoint blockade immunotherapy: A first-in-human study.

被引：0
|
作者：
Nie, Xiaoqian
Yang, Liu
Liu, Yuehua
Chen, Zheling
Gao, Xiaofei
机构：
[1] Westlake Univ, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Prov Peoples Hosp, Hangzhou, Peoples R China
[3] Westlake Univ, Sch Life Sci, Hangzhou, Peoples R China
[4] Westlake Inst Adv Study, Inst Basic Med Sci, Hangzhou, Peoples R China
[5] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Hangzhou, Peoples R China
[6] Westlake Univ, Inst Basic Med Sci, Westlake Inst Adv Study, Sch Life Sci, Hangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2557
引用
收藏
页数：1
相关论文
共 50 条
  • [1] An Erythrocyte-α PD-1 conjugate suppresses cancers resistant to checkpoint blockade immunotherapy: A first-in-human study
    Yang, Liu
    Nie, Xiaoqian
    Chen, Zheling
    Liu, Yuehua
    Zheng, Jiawei
    Gao, Xiaofei
    CANCER RESEARCH, 2024, 84 (06)
  • [2] Innate immunotherapy of neuroblastoma and PD-1 checkpoint blockade
    Lode, Holger
    Zumpe, Maxi
    Juettner, Madlen
    Troschke-Meurer, Sascha
    Janzek, Evelyne
    Schaefer, Romana
    Loibner, Hans
    Siebert, Nikolai
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [3] Mechanisms of Resistance to PD-1 Checkpoint Blockade
    Justin C. Moser
    Siwen Hu-Lieskovan
    Drugs, 2020, 80 : 459 - 465
  • [4] Mechanisms of Resistance to PD-1 Checkpoint Blockade
    Moser, Justin C.
    Hu-Lieskovan, Siwen
    DRUGS, 2020, 80 (05) : 459 - 465
  • [5] Mechanisms of primary resistance to PD-1 checkpoint blockade
    Krogsgaard, Michelle
    Moogk, Duane
    Li, Kaitao
    Yuan, Zhou
    Osman, Iman
    Weber, Jeffrey S.
    Zhu, Cheng
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [6] Metabolically reprogram MDSCs by targeting Pim kinases to overcome resistance to PD-1 blockade immunotherapy
    Chen, Yao
    Topchyan, Paytsar
    Jiang, Aimin
    Chen, Yiliang
    Silverstein, Roy
    Cui, Weiguo
    Xin, Gang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [7] PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer?
    Tanvetyanon, Tawee
    Gray, Jhanelle E.
    Antonia, Scott J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (03) : 305 - 312
  • [8] Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy
    Meng, Xiangjiao
    Huang, Zhaoqin
    Teng, Feifei
    Xing, Ligang
    Yu, Jinming
    CANCER TREATMENT REVIEWS, 2015, 41 (10) : 868 - 876
  • [9] Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
    Xin Wang
    Gaochao Guo
    Hui Guan
    Yang Yu
    Jie Lu
    Jinming Yu
    Journal of Experimental & Clinical Cancer Research, 38
  • [10] Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
    Wang, Xin
    Guo, Gaochao
    Guan, Hui
    Yu, Yang
    Lu, Jie
    Yu, Jinming
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
12345